Because our study provided evidence that in rat brain undergoing perinatal asphyxia, DIM predominantly targets AhR and NMDA, we postulate that compounds that possess the ability to inhibit the signaling are promising therapeutic tools to prevent stroke. The gene discussed is AHR; the disease is stroke disorder.